Vitalhub (TSE:VHI) Given a C$15.00 Price Target by Stifel Nicolaus Analysts

Stifel Nicolaus set a C$15.00 price objective on Vitalhub (TSE:VHI) in a research report sent to investors on Wednesday morning,BayStreet.CA reports. The brokerage currently has a buy rating on the stock.

Other analysts also recently issued research reports about the stock. Royal Bank Of Canada set a C$15.00 price objective on shares of Vitalhub and gave the stock a “moderate buy” rating in a report on Thursday, September 18th. National Bankshares set a C$16.00 price objective on shares of Vitalhub and gave the stock an “outperform” rating in a report on Thursday, August 21st. Raymond James Financial boosted their price objective on shares of Vitalhub from C$14.50 to C$15.00 and gave the stock an “outperform” rating in a report on Tuesday, August 12th. Scotiabank boosted their price objective on shares of Vitalhub from C$14.00 to C$14.50 and gave the stock an “outperform” rating in a report on Friday, June 20th. Finally, TD Securities boosted their price objective on shares of Vitalhub from C$15.00 to C$16.00 and gave the stock a “buy” rating in a report on Monday, August 11th. One analyst has rated the stock with a Strong Buy rating and seven have issued a Buy rating to the company’s stock. Based on data from MarketBeat.com, Vitalhub has a consensus rating of “Buy” and a consensus price target of C$14.86.

Vitalhub Stock Up 0.7%

Shares of TSE:VHI opened at C$10.70 on Wednesday. The company has a market cap of C$672.28 million, a price-to-earnings ratio of 133.75, a PEG ratio of 1.18 and a beta of 0.62. The firm’s 50-day simple moving average is C$11.89 and its 200-day simple moving average is C$11.34. Vitalhub has a fifty-two week low of C$8.50 and a fifty-two week high of C$14.64.

Insider Activity

In other Vitalhub news, Director Danny Matlow sold 150,000 shares of the company’s stock in a transaction dated Thursday, August 28th. The shares were sold at an average price of C$12.75, for a total value of C$1,912,500.00. Following the sale, the director owned 520,001 shares of the company’s stock, valued at C$6,630,012.75. This represents a 22.39% decrease in their ownership of the stock. Also, Director Steve Garrington sold 20,000 shares of the company’s stock in a transaction dated Tuesday, August 19th. The shares were sold at an average price of C$12.90, for a total transaction of C$258,000.00. Following the completion of the sale, the director directly owned 60,000 shares in the company, valued at C$774,000. This trade represents a 25.00% decrease in their position. 18.57% of the stock is owned by corporate insiders.

About Vitalhub

Vitalhub Corp is Canada-based firm that develops technology solutions for health and human services providers in the mental health (child through adult), long term care, community health service, home health, social service, and acute care sectors. Its technologies include blockchain, mobile, patient flow, web-based assessment, and electronic health record solutions.